Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities (original) (raw)

Treatment of Recurrent Sarcoma of the Extremities by Isolated Limb Perfusion Using Tumor Necrosis Factor Alpha and Melphalan

Renato Manzi

Tumori Journal, 1996

View PDFchevron_right

Long-Term Results of Tumor Necrosis Factor - and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas

J. de Wilt

Journal of Clinical Oncology, 2011

View PDFchevron_right

Advanced Extremity Soft Tissue Sarcoma: Prognostic Effect of Isolated Limb Perfusion in a Series of 88 Patients Treated at a Single Institution

Mario Santinami

Annals of Surgical Oncology, 2007

View PDFchevron_right

Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Limb Salvage in 186 Patients with Locally Advanced Soft Tissue Extremity Sarcomas

Alexander Eggermont

Annals of Surgery, 1996

View PDFchevron_right

Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience

Luca Giovanni Campana

International Journal of Hyperthermia, 2015

View PDFchevron_right

Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient

Sylvie Bonvalot, Françoise Rimareix

Annals of Surgical Oncology, 2009

View PDFchevron_right

Isolated limb perfusion with tumor necrosis factor-? and melphalan for patients with unresectable soft tissue sarcoma of the extremities

Frits van Coevorden

Cancer, 2003

View PDFchevron_right

Limb salvage by neoadjuvant isolated perfusion with TNFα and melphalan for non-resectable soft tissue sarcoma of the extremities

François Mosimann

European Journal of Surgical Oncology, 2000

View PDFchevron_right

Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma

Alexander Eggermont

2007

View PDFchevron_right

Isolated limb perfusion with tumor necrosis factor and melphalan for non‐resectable soft tissue sarcomas: Long‐term results on efficacy and limb salvage in a selected …

Robert van Ginkel

Journal of surgical …, 2008

View PDFchevron_right

TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome

Robert van Ginkel

Journal of Surgical Oncology, 2011

View PDFchevron_right

Isolated Limb Perfusions With Tumor Necrosis Factor and Melphalan for Locally Recurrent Soft Tissue Sarcoma in Previously Irradiated Limbs

J. de Wilt

Annals of Surgical Oncology, 2005

View PDFchevron_right

Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma

Mordechai Gutman

European Journal of Surgical Oncology (EJSO), 2009

View PDFchevron_right

Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor

Ineke Molenaar

Annals of Surgical Oncology, 1997

View PDFchevron_right

Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomes

Giovanni Scarzello

European Journal of Surgical Oncology (EJSO), 2017

View PDFchevron_right

Long Term Outcome of Preoperative Isolated Limb Infusion and External Irradiation in Management of Locally Advanced Extremity Soft Tissue Sarcoma

sherif kotb

The Open Surgical Oncology Journal, 2011

View PDFchevron_right

Other primary neoplasms in patients with soft tissue sarcomas of the extremities treated with isolated limb perfusion

Robert van Ginkel

View PDFchevron_right

Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity

Hidde Kroon

Annals of Surgical Oncology, 2008

View PDFchevron_right

Fifty Tumor Necrosis Factor?Based Isolated Limb Perfusions for Limb Salvage in Patients Older Than 75 Years With Limb-Threatening Soft Tissue Sarcomas and Other Extremity Tumors

Alexander Eggermont

Annals of Surgical Oncology, 2003

View PDFchevron_right

The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcoma of the extremities

Renato Cavaliere

World Journal of Surgery, 1988

View PDFchevron_right

The oncological outcomes of isolated limb perfusion and neo-adjuvant radiotherapy in soft tissue sarcoma patients - A nationwide multicenter study

Veroniek van Praag

European Journal of Surgical Oncology

View PDFchevron_right

Soft Tissue Cancer Management: Isolated Limb Infusion for Sarcoma

Pille Pata

Visceral medicine, 2019

View PDFchevron_right

Hyperthermic isolated limb perfusion for recurrent melanomas and soft tissue sarcomas: Feasibility and reproducibility in a multi-institutional Hellenic collaborative study

Christos V Ioannou

Oncology Reports, 2010

View PDFchevron_right

Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremity

Eric Manusama

Ejso, 1999

View PDFchevron_right

Long-term Results of Hyperthermic, Isolated Limb Perfusion for Melanoma

Peter Kam

Annals of Surgery, 2007

View PDFchevron_right

Isolated limb perfusion for unresectable extremity sarcoma

Curtis Wray

Cancer, 2011

View PDFchevron_right

Isolated Limb Perfusion in the Treatment of Advanced Soft-tissue Sarcomas

Martin Malawer

Musculoskeletal Cancer Surgery, 2004

View PDFchevron_right